A Cytokine-Related Gene Signature for Pan-Cancer Prognostic Stratification and Malignant Phenotype Characterization
Authors:
- Shih-Chieh ChenSCShih-Chieh Chen
- Kai-Fu ChangKCKai-Fu Chang
- Chien-Cheng ChaoCCChien-Cheng Chao
- Chung-Hsien LinCLChung-Hsien Lin
- Chih-Hsuan ChangCCChih-Hsuan Chang
- Ching-Chung KoCKChing-Chung Ko
- Hui-Ru LinHLHui-Ru Lin
- Chi-Jen WuCWChi-Jen Wu
- Chien-Han YuanCYChien-Han Yuan
- Sachin KumarSKSachin Kumar
- Dahlak Daniel SolomonDSDahlak Daniel Solomon
- Do Thi Minh XuanDXDo Thi Minh Xuan
Preprint
- 13 February 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Background Cytokines are central regulators of inflammation and immune responses within the tumor microenvironment and have been implicated in cancer progression and prognosis. However, the prognostic value of coordinated cytokine-related transcriptional programs across cancer types has not been systematically explored. Methods Pan-cancer transcriptomic and clinical data were analyzed to construct a cytokine-related prognostic signature using LASSO Cox regression. Patients were stratified into high-risk and low-risk groups based on the derived risk score. Prognostic performance was evaluated in training and test cohorts, and biological relevance was assessed through survival analyses and pathway-level investigations. Results A 16-gene cytokine-related signature was established that consistently stratified patients into distinct prognostic groups across multiple cancer types. High cytokine-related risk scores were significantly associated with unfavorable survival outcomes and were linked to enhanced cell cycle activity, epithelial-mesenchymal transition, and extracellular matrix remodeling. Integration of the risk score with clinical variables improved individualized survival prediction. Immunohistochemical analyses further confirmed increased protein expression of representative risk-associated genes, including PANX1 and FRMD8, in multiple tumor tissues compared with corresponding normal tissues. Conclusions The cytokine-related prognostic signature captures key inflammatory and immune-related programs underlying tumor aggressiveness and provides a robust tool for pan-cancer risk stratification with potential clinical utility.Keywords
All Related Versions
This publication has 44 references indexed in Scilit:
- Integrated Multi-Omics Analysis Reveals Cytokine Network Dynamics and Prognostic Signatures in Hepatitis B Virus-Associated Hepatocellular CarcinomaApplied Biochemistry and Biotechnology, 2026
- Cytokine symphony: Deciphering the tumor microenvironment and metastatic axis in oral cancerCytokine & Growth Factor Reviews, 2025
- Internal validation strategy for high dimensional prognosis model: A simulation study and application to transcriptomic in head and neck tumorsComputational and Structural Biotechnology Journal, 2025
- Cytokines in cancerCancer Cell, 2024
- Interleukin-6 serves as a critical factor in various cancer progression and therapyMedical Oncology, 2024
- The cytokines in tumor microenvironment: from cancer initiation-elongation-progression to metastatic outgrowthCritical Reviews in Oncology/Hematology, 2024
- Distinct spatiotemporal dynamics of CD8+ T cell-derived cytokines in the tumor microenvironmentCancer Cell, 2024
- Cytokine profiles in patients with newly diagnosed diffuse large B-cell lymphoma: IL-6 and IL-10 levels are associated with adverse clinical features and poor outcomesCytokine, 2023
- Prognostic nomogram incorporating cytokines for overall survival in patients with newly diagnosed multiple myelomaInternational Immunopharmacology, 2021
- Targeted Proteomics-Based Quantitative Protein Atlas of Pannexin and Connexin Subtypes in Mouse and Human Tissues and Cancer Cell LinesJournal of Pharmaceutical Sciences, 2020